Exploring Best Practices on Development Regulatory Affairs and Clinical Development Related to Multiregional Clinical Trials (MRCTs) in China, Korea, and Taiwan

Editor’s Note: In this Meeting Report, Tetsuomi Takano provides an excellent summary of 2 related tutorial sessions held at the DIA 6th Annual Conference in Japan for Asian New Drug Development (KFC Hall, Tokyo, Japan, April 27, 2012). The sessions focused on best practices for development regulatory affairs and clinical development related to multiregional clinical trials (MRCTs) in China, Korea and Taiwan. I am grateful to Mr Takano for this contribution to the journal, and I am sure readers will find it both interesting and educational. J. Rick Turner, Outgoing Editor-in-Chief